- Home
- AGRO vs LXEO Comparison
AGRO vs LXEO Comparison
Compare AGRO & LXEO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | AGRO | LXEO |
|---|---|---|
| Founded | 2002 | 2017 |
| Country | Luxembourg | United States |
| Employees | N/A | N/A |
| Industry | Farming/Seeds/Milling | |
| Sector | Consumer Staples | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 813.7M | 663.5M |
| IPO Year | 2011 | 2023 |
Fundamental Metrics
Financial Performance| Metric | AGRO | LXEO |
|---|---|---|
| Price | $7.38 | $9.68 |
| Analyst Decision | Sell | Strong Buy |
| Analyst Count | 3 | 9 |
| Target Price | $8.17 | ★ $18.22 |
| AVG Volume (30 Days) | ★ 1.1M | 980.7K |
| Earning Date | 11-11-2025 | 11-05-2025 |
| Dividend Yield | ★ 4.91% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.23 | N/A |
| Revenue | ★ $1,386,018,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $30.64 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $6.89 | $1.45 |
| 52 Week High | $11.79 | $10.38 |
Technical Indicators
Market Signals| Indicator | AGRO | LXEO |
|---|---|---|
| Relative Strength Index (RSI) | 40.99 | 56.50 |
| Support Level | $6.89 | $9.48 |
| Resistance Level | $7.65 | $10.56 |
| Average True Range (ATR) | 0.38 | 0.59 |
| MACD | -0.10 | 0.02 |
| Stochastic Oscillator | 23.64 | 61.95 |
Price Performance
Historical ComparisonAbout AGRO Adecoagro S.A.
Adecoagro SA is a Luxembourg-based agricultural company. It is involved in a wide range of businesses, including farming crops and other agricultural products, dairy operations sugar, ethanol, energy production, and land transformation. The group operates in two lines of business, namely, Farming and Sugar, Ethanol and Energy. The Farming is further comprised of three reportable segments: Crops, Rice and Dairy. Sugar, Ethanol and Energy Segment, consists of cultivating sugarcane, which is processed in owned sugar mills, transformed into ethanol, sugar and electricity, in addition to biomethane and then marketed.
About LXEO Lexeo Therapeutics Inc.
Lexeo Therapeutics Inc is a clinical-stage genetic medicines company committed to transforming healthcare by applying pioneering science to fundamentally alter how diseases are treated. The company focuses on preclinical and clinical stage gene therapies, specifically hereditary and acquired diseases with high unmet needs, which represent its sole business segment.